欧盟EMA药品数据库-欧盟集中审批药品
（European Medicines Agency Authorisation of Medicines DataBase）
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
*Search by Medicine name,INN,Active substance,Product number.
高级搜索
数据记录共 2687 条，共 135 页，当前第 11 页
可点击列名称排序
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Fluenz Human influenza vaccine (live attenuated, nasal) influenza virus A/Victoria/4897/2022  (H1N1)pdm09 - like strain (A/Norway/31694/2022, MEDI 369815), A A/Croatia/10136RV/2023 (H3N2)-like strain (A/Perth/722/2024, MEDI 392611) B/Austria/1359417/2021 - like strain (B/ Austria/1359417/2021, MEDI 355292) EMEA/H/C/006514 AstraZeneca AB 2024/06/03 Authorised
Qalsody Human tofersen tofersen EMEA/H/C/005493 Biogen Netherlands B.V.  2024/05/29 Authorised
Agilus Human dantrolene sodium, hemiheptahydrate dantrolene sodium, hemiheptahydrate EMEA/H/C/006009 Norgine B.V. 2024/05/29 Authorised
Lytenava Human bevacizumab bevacizumab EMEA/H/C/005723 Outlook Therapeutics NL B. V. 2024/05/27 Authorised
Neoatricon Human dopamine hydrochloride dopamine hydrochloride;Dopamine EMEA/H/C/006044 BrePco Biopharma Limited 2024/05/27 Authorised
Fabhalta Human iptacopan iptacopan hydrochloride monohydrate EMEA/H/C/005764 Novartis Europharm Limited 2024/05/17 Authorised
Awiqli Human insulin icodec insulin icodec EMEA/H/C/005978 Novo Nordisk A/S 2024/05/17 Authorised
Wyost Human denosumab denosumab EMEA/H/C/006378 Sandoz GmbH 2024/05/17 Authorised
Omlyclo Human omalizumab omalizumab EMEA/H/C/005958 Celltrion Healthcare Hungary Kft. 2024/05/16 Authorised
Jubbonti Human denosumab denosumab EMEA/H/C/005964 Sandoz GmbH 2024/05/16 Authorised
Dimethyl fumarate Mylan Human dimethyl fumarate dimethyl fumarate EMEA/H/C/006397 Mylan Pharmaceuticals Limited 2024/04/22 Authorised
Emblaveo Human aztreonam;avibactam avibactam;aztreonam EMEA/H/C/006113 Pfizer Europe MA EEIG 2024/04/22 Authorised
Dimethyl fumarate Accord Human dimethyl fumarate dimethyl fumarate EMEA/H/C/006471 Accord Healthcare Ltd 2024/04/22 Authorised
Dimethyl fumarate Neuraxpharm Human dimethyl fumarate dimethyl fumarate EMEA/H/C/006500 Neuraxpharm Pharmaceuticals S.L. 2024/04/22 Authorised
Zynyz Human retifanlimab retifanlimab EMEA/H/C/006194 Incyte Biosciences Distribution B.V. 2024/04/19 Authorised
Apremilast Accord Human apremilast apremilast EMEA/H/C/006208 Accord Healthcare S.L.U. 2024/04/19 Authorised
Voydeya Human danicopan danicopan EMEA/H/C/005517 Alexion Europe SAS 2024/04/19 Authorised
Filspari Human sparsentan sparsentan EMEA/H/C/005783 Vifor France 2024/04/19 Authorised
Incellipan Human pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen EMEA/H/C/006051 Seqirus Netherlands B.V. 2024/04/19 Authorised
Pyzchiva Human ustekinumab ustekinumab EMEA/H/C/006183 Samsung Bioepis NL B.V. 2024/04/19 Authorised

数据库说明：

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase